A Phase 2, Multi-center, Randomized, Double-masked, Placebo (Vehicle)-Controlled Clinical Study With an Open Label Comparator Arm to Assess the Efficacy, Safety and Tolerability of Topical CyclASol for Treatment of Dry Eye Disease

Trial Profile

A Phase 2, Multi-center, Randomized, Double-masked, Placebo (Vehicle)-Controlled Clinical Study With an Open Label Comparator Arm to Assess the Efficacy, Safety and Tolerability of Topical CyclASol for Treatment of Dry Eye Disease

Completed
Phase of Trial: Phase II

Latest Information Update: 09 Nov 2017

At a glance

  • Drugs Ciclosporin (Primary)
  • Indications Dry eyes
  • Focus Therapeutic Use
  • Sponsors Novaliq
  • Most Recent Events

    • 09 Nov 2017 According to a Novaliq media release, data will be presented at AAO 2017, the American Academy of Ophthalmologys 121st annual meeting.
    • 28 Mar 2017 Status changed from active, no longer recruiting to completed.
    • 05 Jan 2017 Top-line results published in a Novaliq media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top